AstraZeneca signs on Albany Molecular to help boost COVID-19 shot production

British drugmaker AstraZeneca is on a mission to lock in as many manufacturing partners as possible to support a planned global rollout for its COVID-19 vaccine frontrunner. A New York CDMO has now jumped on board, and it will commit its Southwestern facility to help pick up the slack.

New York-based Albany Molecular Research will pick up fill-finish duties for "millions of doses" of AstraZeneca and the University of Oxford's adenovirus-based COVID-19 shot at its Albuquerque, New Mexico site, the CDMO said Thursday.